Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1099)
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
65,517
Price
$81.74
Total Value
$5.36M
Shares Held After
13,896
% of Holdings
82.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
43,505
Price
$80.69
Total Value
$3.51M
Shares Held After
79,413
% of Holdings
35.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
33,830
Price
$81.48
Total Value
$2.76M
Shares Held After
0
% of Holdings
100.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
523
Price
$36.77
Total Value
$19.23K
Shares Held After
16,300
% of Holdings
3.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
4,477
Price
$36.08
Total Value
$161.53K
Shares Held After
16,823
% of Holdings
21.0%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,662
Price
$64.08
Total Value
$170.58K
Shares Held After
396,920
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
300,000
Price
$5.00
Total Value
$1.50M
Shares Held After
0
% of Holdings
100.0%
ONCOLYTICS BIOTECH INC (ONCY)
Kelly Jared — Director
Shares
5,050
Price
$0.96
Total Value
$4.85K
Shares Held After
114,050
% of Holdings
4.4%
Lineage Cell Therapeutics, Inc. (LCTX)
Culley Brian M — Director
Shares
15,000
Price
$1.62
Total Value
$24.38K
Shares Held After
255,516
% of Holdings
5.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.08
Total Value
$268.36K
Shares Held After
516,610
% of Holdings
3.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
122,523
Price
$13.17
Total Value
$1.61M
Shares Held After
520,948
% of Holdings
19.0%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
30,593
Price
$14.08
Total Value
$430.75K
Shares Held After
291,374
% of Holdings
9.5%
Adaptive Biotechnologies Corp (ADPT)
GRIFFIN MICHELLE RENEE — Director
Shares
15,394
Price
$13.91
Total Value
$214.13K
Shares Held After
15,625
% of Holdings
49.6%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
329,600
Price
$13.17
Total Value
$4.34M
Shares Held After
2,301,113
% of Holdings
12.5%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
140,567
Price
$13.17
Total Value
$1.85M
Shares Held After
2,630,713
% of Holdings
5.1%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
41,338
Price
$13.17
Total Value
$544.42K
Shares Held After
427,775
% of Holdings
8.8%
Adaptive Biotechnologies Corp (ADPT)
BENZENO SHARON — Chief Commercial Ofc Imm Med
Shares
63,103
Price
$13.17
Total Value
$831.07K
Shares Held After
272,751
% of Holdings
18.8%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
329,600
Price
$13.17
Total Value
$4.34M
Shares Held After
1,522,058
% of Holdings
17.8%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
18,672
Price
$13.17
Total Value
$245.91K
Shares Held After
259,840
% of Holdings
6.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
140,666
Price
$13.17
Total Value
$1.85M
Shares Held After
1,851,658
% of Holdings
7.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
3,418
Price
$75.86
Total Value
$259.29K
Shares Held After
1,152,987
% of Holdings
0.3%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,219
Price
$74.83
Total Value
$615.03K
Shares Held After
1,156,405
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,363
Price
$74.29
Total Value
$621.29K
Shares Held After
1,164,624
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
3,057
Price
$225.00
Total Value
$687.83K
Shares Held After
21,010
% of Holdings
12.7%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
341
Price
$300.00
Total Value
$102.30K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
129,672
Price
$19.52
Total Value
$2.53M
Shares Held After
4,644,386
% of Holdings
2.7%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$19.35
Total Value
$38.70K
Shares Held After
13,500
% of Holdings
14.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,633
Price
$498.42
Total Value
$1.31M
Shares Held After
12,489
% of Holdings
17.4%
ONCOLYTICS BIOTECH INC (ONCY)
Parsons James T. — Director
Shares
10,000
Price
$1.03
Total Value
$10.30K
Shares Held After
41,849
% of Holdings
23.9%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Guyer Charles Greg — EVP, Chief Technical Officer
Shares
16,486
Price
$60.46
Total Value
$996.74K
Shares Held After
79,953
% of Holdings
17.1%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
2,800
Price
$52.80
Total Value
$147.84K
Shares Held After
87,815
% of Holdings
3.1%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
9,798
Price
$52.80
Total Value
$517.33K
Shares Held After
235,558
% of Holdings
4.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
1,067
Price
$19.08
Total Value
$20.36K
Shares Held After
1,109,905
% of Holdings
0.1%
NewAmsterdam Pharma Co N.V. (NAMS)
LANGE LOUIS G — Director
Shares
446
Price
$31.23
Total Value
$13.93K
Shares Held After
10,360
% of Holdings
4.1%
NewAmsterdam Pharma Co N.V. (NAMS)
LANGE LOUIS G — Director
Shares
44,173
Price
$30.41
Total Value
$1.34M
Shares Held After
10,806
% of Holdings
80.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$21.55
Total Value
$21.55K
Shares Held After
38,415
% of Holdings
2.6%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
11,111
Price
$83.72
Total Value
$930.21K
Shares Held After
68,052
% of Holdings
14.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
12,882
Price
$83.10
Total Value
$1.07M
Shares Held After
79,163
% of Holdings
14.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,765
Price
$82.13
Total Value
$144.96K
Shares Held After
92,045
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
300
Price
$544.76
Total Value
$163.43K
Shares Held After
130
% of Holdings
69.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$544.20
Total Value
$631.28K
Shares Held After
430
% of Holdings
73.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$543.04
Total Value
$130.33K
Shares Held After
1,590
% of Holdings
13.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,178
Price
$542.13
Total Value
$638.63K
Shares Held After
1,830
% of Holdings
39.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
942
Price
$541.04
Total Value
$509.66K
Shares Held After
3,008
% of Holdings
23.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$540.07
Total Value
$453.66K
Shares Held After
3,950
% of Holdings
17.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,095
Price
$538.92
Total Value
$590.12K
Shares Held After
4,790
% of Holdings
18.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,106
Price
$538.01
Total Value
$595.04K
Shares Held After
5,885
% of Holdings
15.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$536.95
Total Value
$652.39K
Shares Held After
6,991
% of Holdings
14.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$535.82
Total Value
$441.51K
Shares Held After
8,206
% of Holdings
9.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$533.47
Total Value
$128.03K
Shares Held After
9,030
% of Holdings
2.6%
Showing 301–350 of 1099 transactions (page 7 of 22)